Wealthfront Advisers LLC bought a new position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 20,861 shares of the semiconductor company's stock, valued at approximately $9,305,000.
Other large investors have also recently modified their holdings of the company. Sankala Group LLC purchased a new position in Synopsys during the fourth quarter worth $25,000. Elevation Wealth Partners LLC raised its stake in shares of Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock valued at $25,000 after acquiring an additional 27 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Synopsys in the fourth quarter valued at $28,000. IMG Wealth Management Inc. bought a new stake in shares of Synopsys in the 2nd quarter worth about $28,000. Finally, Atlas Capital Advisors Inc. purchased a new position in shares of Synopsys during the 4th quarter worth about $32,000. Institutional investors own 85.47% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on SNPS shares. Rosenblatt Securities upped their price target on shares of Synopsys from $530.00 to $575.00 and gave the company a "buy" rating in a report on Tuesday, May 26th. Citigroup raised their price objective on shares of Synopsys from $600.00 to $610.00 and gave the stock a "buy" rating in a research note on Thursday, May 28th. Wells Fargo & Company dropped their target price on Synopsys from $535.00 to $450.00 and set an "equal weight" rating for the company in a research report on Tuesday, August 11th. BNP Paribas Exane upped their target price on Synopsys from $425.00 to $450.00 and gave the company an "underperform" rating in a research note on Thursday, May 28th. Finally, KeyCorp reiterated an "overweight" rating on shares of Synopsys in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Synopsys has an average rating of "Moderate Buy" and a consensus price target of $563.59.
Read Our Latest Report on SNPS
Synopsys Stock Performance
SNPS stock opened at $401.24 on Thursday. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $615.79. The business has a 50-day moving average price of $422.02 and a 200 day moving average price of $440.99. The company has a market capitalization of $76.83 billion, a P/E ratio of 92.88, a PEG ratio of 2.38 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to analysts' expectations of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm's quarterly revenue was up 41.9% on a year-over-year basis. During the same period in the prior year, the business earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities research analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.
Insider Buying and Selling
In related news, CEO Sassine Ghazi sold 14,603 shares of the business's stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company's stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company's stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company's stock, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by company insiders.
About Synopsys
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.